Aperture Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1030 Brittan Ave, San Carlos, California...Website
www.aperturetx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Aperture Therapeutics
Aperture Therapeutics is developing an innovative drug discovery platform focused on curing neurodegenerative diseases and delaying brain aging. The company utilizes machine learning to analyze genomic and clinical data, identifying protective gene variants that can be mimicked through oligonucleotide therapeutics. Their approach targets both familial and sporadic forms of diseases like ALS and FTD, expanding the potential patient population and commercial opportunities. By leveraging human genetics, they aim to minimize translational risks associated with traditional drug development methods.Explore more
Aperture Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aperture Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aperture Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Aperture Therapeutics had a recent Job posting/layoffs
Check if Aperture Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Aperture Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Aperture Therapeutics
Funding: Get notified immidiatlly once Aperture Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aperture Therapeutics recently announced quarterly report
Check out if Aperture Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Aperture Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Aperture Therapeutics
Compare insights from companies similar to Aperture Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aperture Therapeutics
<$5M
1-10
Private
-
2022
ES
Ekaterina StomakhinaSenior Research, Vivo Pharmacology Assistant III
Company Profile Activity
Activity Insights
Aperture Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aperture Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aperture Therapeutics.
Aperture Therapeutics Tech Stack
A closer look at the technologies used by Aperture Therapeutics
Most Recent Scoops
Person-Based
Person-Based
Funding
Project
Spending/Investment, Funding
Funding
Project
Aperture Therapeutics News & Media
Aperture Therapeutics Announces Development Candidate Targeting CD33 to Restore Microglial Homeostasis in FTD and ALS
SAN CARLOS, Calif., Nov. 19, 2025 /PRNewswire/ -- Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the nomination of APRTX-001 as its development candidate. APRTX-001 is a CD33-targeting antisense...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Aperture Therapeutics
Sign Up For FreeTo access detailed company insights
Aperture Therapeutics is developing an innovative drug discovery platform focused on curing neurodegenerative diseases and delaying brain aging. The company utilizes machine learning to analyze genomic and clinical data, identifying protective gene variants that can be mimicked through oligonucleotide therapeutics. Their approach targets both famil... Read More
